New CEO to CathPrint2010-08-31 Johan Järte takes office on 1 September as CEO in CathPrint AB, a medical technology company in Life Science.
The company CathPrint ™, offers a catheter design and manufacturing, which streamlines the existing catheter production and provides opportunities to develop challenging concepts into marketable products. This leads to significant cost savings, improved performance and increased profitability for the company that will use the technology. CathPrint AB designs and manufactures catheters in close cooperation with customers.
Johan Järte comes from the company SentoClone, where he was CEO, the company developed into a respected research company with its own GMP production. Previously, John fifteen years of experience in various management positions in the pharmaceutical industry and prior training of specialist doctors.
"CathPrint technology has shown very promising results and is now ready to be commercialized. With the technical advantages CathPrint have is a huge market waiting. Getting the part in introducing this method is both important and stimulating. Together with the employees at CathPrint I hope to contribute to the spread of technology not only in Sweden but also in other parts of the world, "said John Järte.
"We think it is very helpful to John, both have built enterprises and that he is a doctor with experience of catheters. In our development it is important to get rapid feedback from end users and to be able to bounce early ideas and design proposals. We welcome Johan hot welcome to our company, "says Bengt Källbäck, founder and principal owner, and Anders Broms, Chairman.
CathPrint developed in the business incubator and venture capital STING STING Capital is an investor in the company.